Beta Drugs Limited share price
NSE: BETA · ISIN INE351Y01019
Key numbers
- Market cap
- ₹ 2,127 Cr
- Current price
- ₹ 2,098.70
- 52-week high / low
- ₹ 2,808 / 990
- Stock P/E
- 47.5
- Book value
- ₹ 241.6
- Dividend yield
- 0.00%
- ROCE
- 19.1%
- ROE
- 18.8%
- Debt to equity
- 0.60
- Sales growth (3 yrs)
- 19.2%
- Profit growth (3 yrs)
- 10.5%
- 1-year return
- 14.4%
About Beta Drugs Limited
Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 100 | 103 | 87 | 94 | 126 |
| Operating profit | 20 | 21 | 17 | 18 | 27 |
| Net profit | 12 | 12 | 9 | 9 | 16 |
| EPS (₹) | 11.59 | - | 8.40 | 8.93 | 14.78 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.